Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Breast cancer and Metastatic breast cancer, with related work in Nuclear medicine, Atezolizumab, Oncology. Notable publications include '89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer', 'Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition', and 'Clinical Validity of 16α-[ 18 F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer'.
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer
Clinical Validity of 16α-[<sup>18</sup>F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
Assessment of Bone Lesions with<sup>18</sup>F-FDG PET Compared with<sup>99m</sup>Tc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer